Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 13 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

15%

2 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
5(62.5%)
Phase 4
2(25.0%)
Phase 2
1(12.5%)
8Total
N/A(5)
Phase 4(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials
NCT07352878Not Yet Recruiting

Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece.

Role: collaborator

NCT06919029Recruiting

Effect of Advanced Hybrid Closed Loop System, MiniMed 780G in Newly Diagnosed Children and Adolescents With Type 1 Diabetes on Glycemic Control and Patient Reported Outcomes Compared to Standard Insulin Therapy Historical Data (AHCL in New Onset T1D Children Study)

Role: collaborator

NCT06831799Completed

ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

Role: collaborator

NCT01918007Not ApplicableCompleted

Adenotonsillectomy for Obstructive Sleep-Disordered Breathing in Childhood:The Chania Community Oximetry-Based Study

Role: collaborator

NCT03547050Completed

Rolandic Epilepsy Genomewide Association International Study

Role: collaborator

NCT04824326Not ApplicableCompleted

The Effects of Pythagorean Self-Awareness Intervention on Young Adolescents in Primary School-Α One Arm Clinical Trial

Role: collaborator

NCT04763525Not ApplicableCompleted

Efficacy of Pythagorean Self-Awareness for Aging Biomarkers Improvement, in T2D Patients and Healthy Individuals.

Role: collaborator

NCT02383329Not ApplicableCompleted

Effects of Oral Nutrition Supplements in Children With Disease Associated Underweight

Role: collaborator

NCT03405805Unknown

Immunological Memory Against Pneumococcus Induced by 3 Infant PCV 13 Vaccination Schedules

Role: lead

NCT03041051Phase 4Unknown

Immunological Memory Induced by the 13valent Pneumococcal Conjugate(PCV13) and 23valent Plain Polysaccharide Vaccine(PPV23) in HIV-infected Patients

Role: lead

NCT01719107Not ApplicableCompleted

Efficacy of Dietary Supplementation With Lactobacilllus Reuteri DSM 17938 on Functional Abdominal Pain (FAP) in Children

Role: lead

NCT01846923Phase 4Unknown

B Memory Cell Response to Vaccination With the 13-valent Pneumococcal Conjugate Vaccine in Asplenic Individuals

Role: lead

NCT00629694Phase 2Completed

Adenoidectomy, Myringotomy and Tubes' Insertion vs Adenoidectomy and Myringotomy Alone in Children With Otitis Media With Effusion and Adenoid Hypertrophy

Role: lead

All 13 trials loaded